Lauge Farnaes

Lauge Farnaes

Private Equity Investor at Flagship Pioneering

Finance
Consumer Services

Profile

Lauge Farnaes, M.D.
joined Flagship Pioneering in 2021 as Senior Director, Explorations and Clinical Development for Pioneering Medicines.
He is responsible for supporting opportunities with Flagship platform companies and external strategic partners to advance Pioneering Medicines’ portfolio of therapeutics programs.
He also contributes to the strategic clinical development of Pioneering Medicines’ portfolio—from conceiving medicine concepts to developing assets through to human proof-of-concept.
Lauge is a trained pediatric hematologist-oncologist and pediatric infectious disease physician who brings strong clinical experience as well as expertise in genetic disorders, infectious disease detection, and nucleic acid-based diagnostics to this role.
Prior to joining Pioneering Medicines, Lauge was Head of Medical and Scientific Affairs at IDbyDNA, an infectious disease diagnostics start up, where he focused on the clinical outcomes and health economics of advanced genetic testing.
Previously, he was the Assistant Medical Director at the Rady Children’s Institute for Genomic Medicine, where he pioneered the use of rapid whole genome sequencing to diagnose rare genetic disorders in critically ill children.
Lauge received his M.D.
from the University of California San Diego, where he also earned his Ph.D.
in Oceanography, M.S.
in Biology, B.S.
in Biochemistry, and B.A.
in Anthropology.

Lauge Farnaes active positions

CompaniesPositionStart
Private Equity Investor 2021-07-31
All active positions of Lauge Farnaes

Training of Lauge Farnaes

University of California San Diego Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lauge Farnaes's experience

Connections

100 +

1st degree connections

2

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies1

Finance

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW